Thierry Pedrazzini

Prof. Thierry Pedrazzini

University of Lausanne Medical School
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2021 in Nature
Verified
Journal Article
Closed access
PDF file
TKTatjana Kleele
Tatjana Kleele
TRTimo Rey
Timo Rey
JWJulius Winter
Julius Winter
SZSofia Zaganelli
Sofia Zaganelli
DMDora Mahecic
Dora Mahecic
SMSuliana Manley
Suliana Manley

21 June 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
RMRudi Micheletti
Rudi Micheletti
IPIsabelle Plaisance
Isabelle Plaisance
BABrian J. Abraham
Brian J. Abraham
ASAlexandre Sarre
Alexandre Sarre
CTChing-Chia Ting
Ching-Chia Ting
TPThierry Pedrazzini
Thierry Pedrazzini
A super-enhancer–associated long noncoding RNA,Wisper, controls cardiac fibrosis and pathological remodeling in the damaged heart.

1 December 2015 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Open access
SOSamir Ounzain
Samir Ounzain
RMRudi Micheletti
Rudi Micheletti
CACarme Arnan
Carme Arnan
IPIsabelle Plaisance
Isabelle Plaisance
DCDario Cecchi
Dario Cecchi
TPThierry Pedrazzini
Thierry Pedrazzini
Long noncoding RNAs (lncRNAs) are emerging as important regulators of developmental pathways. However, their roles in human cardiac precursor cell (CPC) remain unexplored. To characterize the long noncoding transcriptome during human CPC cardiac differentiation, we profiled the lncRNA transcriptome in CPCs isolated from the human fetal heart and identified 570 lncRNAs that were modulated during cardiac differentiation. Many of these were associated with active cardiac enhancer and super enhancers (SE) with their expression being correlated with proximal cardiac genes. One of the most upregulated lncRNAs was a SE-associated lncRNA that was named CARMEN, (CAR)diac (M)esoderm (E)nhancer-associated (N)oncoding RNA. CARMEN exhibits RNA-dependent enhancing activity and is upstream of the cardiac mesoderm-specifying gene regulatory network. Interestingly, CARMEN interacts with SUZ12 and EZH2, two components of the polycomb repressive complex 2 (PRC2). We demonstrate that CARMEN knockdown inhibits cardiac specification and differentiation in cardiac precursor cells independently of MIR-143 and -145 expression, two microRNAs located proximal to the enhancer sequences. Importantly, CARMEN expression was activated during pathological remodeling in the mouse and human hearts, and was necessary for maintaining cardiac identity in differentiated cardiomyocytes. This study demonstrates therefore that CARMEN is a crucial regulator of cardiac cell differentiation and homeostasis.

30 April 2014 in European Heart Journal
Verified
Journal Article
Open access
PDF file
SOSamir Ounzain
Samir Ounzain
RMRudi Micheletti
Rudi Micheletti
TBTal Beckmann
Tal Beckmann
BSBlanche Schroen
Blanche Schroen
MAMichael Alexanian
Michael Alexanian
TPThierry Pedrazzini
Thierry Pedrazzini
Heart disease is recognized as a consequence of dysregulation of cardiac gene regulatory networks. Previously, unappreciated components of such networks are the long non-coding RNAs (lncRNAs). Their roles in the heart remain to be elucidated. Thus, this study aimed to systematically characterize the cardiac long non-coding transcriptome post-myocardial infarction and to elucidate their potential roles in cardiac homoeostasis. We annotated the mouse transcriptome after myocardial infarction via RNA sequencing and ab initio transcript reconstruction, and integrated genome-wide approaches to associate specific lncRNAs with developmental processes and physiological parameters. Expression of specific lncRNAs strongly correlated with defined parameters of cardiac dimensions and function. Using chromatin maps to infer lncRNA function, we identified many with potential roles in cardiogenesis and pathological remodelling. The vast majority was associated with active cardiac-specific enhancers. Importantly, oligonucleotide-mediated knockdown implicated novel lncRNAs in controlling expression of key regulatory proteins involved in cardiogenesis. Finally, we identified hundreds of human orthologues and demonstrate that particular candidates were differentially modulated in human heart disease. These findings reveal hundreds of novel heart-specific lncRNAs with unique regulatory and functional characteristics relevant to maladaptive remodelling, cardiac function and possibly cardiac regeneration. This new class of molecules represents potential therapeutic targets for cardiac disease. Furthermore, their exquisite correlation with cardiac physiology renders them attractive candidate biomarkers to be used in the clinic.

19 November 2012 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MNMohamed Nemir
Mohamed Nemir
MMMélanie Metrich
Mélanie Metrich
IPIsabelle Plaisance
Isabelle Plaisance
MLMario Lepore
Mario Lepore
SCSteeve Cruchet
Steeve Cruchet
TPThierry Pedrazzini
Thierry Pedrazzini
In the adult heart, Notch signalling regulates the response to injury. Notch inhibition leads to increased cardiomyocyte apoptosis, and exacerbates the development of cardiac hypertrophy and fibrosis. The role of Notch in the mesenchymal stromal cell fraction, which contains cardiac fibroblasts and cardiac precursor cells, is, however, largely unknown. In the present study, we evaluate, therefore, whether forced activation of the Notch pathway in mesenchymal stromal cells regulates pathological cardiac remodelling. We generated transgenic mice overexpressing the Notch ligand Jagged1 on the surface of cardiomyocytes to activate Notch signalling in adjacent myocyte and non-myocyte cells. In neonatal transgenic mice, activated Notch sustained cardiac precursor and myocyte proliferation after birth, and led to increased numbers of cardiac myocytes in adult mice. In the adult heart under pressure overload, Notch inhibited the development of cardiomyocyte hypertrophy and transforming growth factor-β/connective tissue growth factor-mediated cardiac fibrosis. Most importantly, Notch activation in the stressed adult heart reduced the proliferation of myofibroblasts and stimulated the expansion of stem cell antigen-1-positive cells, and in particular of Nkx2.5-positive cardiac precursor cells. We conclude that Notch is pivotal in the healing process of the injured heart. Specifically, Notch regulates key cellular mechanisms in the mesenchymal stromal cell population, and thereby controls the balance between fibrotic and regenerative repair in the adult heart. Altogether, these findings indicate that Notch represents a unique therapeutic target for inducing regeneration in the adult heart via mobilization of cardiac precursor cells.

1 November 2014 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Open access
SOSamir Ounzain
Samir Ounzain
IPIole Pezzuto
Iole Pezzuto
RMRudi Micheletti
Rudi Micheletti
FBFrédéric Burdet
Frédéric Burdet
RSRazan Sheta
Razan Sheta
TPThierry Pedrazzini
Thierry Pedrazzini
The key information processing units within gene regulatory networks are enhancers. Enhancer activity is associated with the production of tissue-specific noncoding RNAs, yet the existence of such transcripts during cardiac development has not been established. Using an integrated genomic approach, we demonstrate that fetal cardiac enhancers generate long noncoding RNAs (lncRNAs) during cardiac differentiation and morphogenesis. Enhancer expression correlates with the emergence of active enhancer chromatin states, the initiation of RNA polymerase II at enhancer loci and expression of target genes. Orthologous human sequences are also transcribed in fetal human hearts and cardiac progenitor cells. Through a systematic bioinformatic analysis, we identified and characterized, for the first time, a catalog of lncRNAs that are expressed during embryonic stem cell differentiation into cardiomyocytes and associated with active cardiac enhancer sequences. RNA-sequencing demonstrates that many of these transcripts are polyadenylated, multi-exonic long noncoding RNAs. Moreover, knockdown of two enhancer-associated lncRNAs resulted in the specific downregulation of their predicted target genes. Interestingly, the reactivation of the fetal gene program, a hallmark of the stress response in the adult heart, is accompanied by increased expression of fetal cardiac enhancer transcripts. Altogether, these findings demonstrate that the activity of cardiac enhancers and expression of their target genes are associated with the production of enhancer-derived lncRNAs.